Expression of the cytokine interleukin la (IL-la) was demonstrated in the rat PC12 pheochromocytoma cell line by (i) immunohistochemistry using rabbit polyclonal antisera raised against the recombinant murine IL-la, (it) an ELISA, and (i) a specific cell conversion bioassay based on the use of LBRM33-1A5 cells. IL-la mRNA was demonstrated in the PC12 cells, by PCR amplification. Constitutive expression of IL-la in PC12 cells was demonstrated in all experiments, although the cellular levels of IL-la-like immunoreactivity varied. The expression of IL-la, as studied at the mRNA level, was inducible by mouse nerve growth factor (7S NGF), and the gene product level was inducible in-a dose-and time-dependent fashion by 7S NGF. The maxmum induction corresponds to a 600% increase in IL-la-like immunoreactivity above the expression level found in noninduced cells and occurred after Interleukin la and 13 (IL-la and IL-1p), the endogenous pyrogen/lymphocyte-activating factors were first identified as products of lipopolysaccharide-stimulated macrophages (1). Both IL-la and IL-1,B have numerous effects on the nervous system besides their role as immune mediators (2). The most important effects of IL-1 on the nervous system include stimulation of corticotropin releasing factor and corticotropin release (3), slow wave sleep (4), and fever (1).
Interleukin la and 13 (IL-la and IL-1p), the endogenous pyrogen/lymphocyte-activating factors were first identified as products of lipopolysaccharide-stimulated macrophages (1) . Both IL-la and IL-1,B have numerous effects on the nervous system besides their role as immune mediators (2) . The most important effects of IL-1 on the nervous system include stimulation of corticotropin releasing factor and corticotropin release (3), slow wave sleep (4) , and fever (1).
We have been focusing on the question of whether the neuronally active substances IL-la and IL-1,B could also be of neuronal origin. Recent reports indicate that IL-1-like immunoreactivity (IL-i-LI) can be found in the human hypothalamus (5) and the rat hippocampus and olfactory bulb (6) . IL-1l3 mRNA has been detected in the rat hippocampus upon convulsant treatment (7) and was also found to be colocalized with nerve growth factor (NGF) mRNA in hippocampal pyramidal cells (8) .
We have earlier shown, by means of immunohistochemistry, that IL-la is localized in peripheral nerves (24) with a distribution closely resembling that of sympathetic noradrenergic innervation and in the noradrenergic chromaffin cells of the rat and mouse adrenal medulla (9) . It was also shown that in vivo treatment of rats with cholinergic agonists, known to stimulate the release of the content of the chromaffin cells, caused a significant decline in the adrenal IL-la content. This suggests that IL-la can be released in a similar fashion to catecholamines, neuropeptide Y, and enkephalins (10) .
To further study the expression and release of IL-la in chromaffin cells, we have turned to the well-established pheochromocytoma PC12 cell line, which has been widely used as a model system in studies of sympathetic neuronal function and development. It also enabled us to examine the regulation of IL-la expression by NGF, which stimulates neurite outgrowth and regulates the expression of a wide variety of proteins in PC12 cells (11) (12) (13) .
The analysis of NGF effects on the expression of IL-1, in relation to the numerous neuronal effects of IL-1, is particularly interesting in view of the demonstration that IL-1 can induce NGF expression in injured sciatic nerve (14) . Furthermore, IL-1 itself acts as a growth factor for astroglia (15, 16) . There is thus a possibility that the growth factors IL-1 and NGF may be expressed and released at the same sites and act in a concerted fashion. Recent findings of the colocalization of mRNA coding for IL-1l3 and NGF in the rat brain (8) also suggest such a possibility. Although almost all cell types studied so far express both IL-la and IL-1p (2), these proteins are products of separate genes, and the present report concentrates on expression of IL-la. In the present study, using a single cell type, the PC12 pheochromocytoma cells, we show that these cells constitutively express the cytokine IL-la and that the level of this expression is subject to regulation by NGF. calf serum, 2 mM L-glutamine, and gentamycin (50 Ag/ml).
MATERIALS AND METHODS
The culture medium of the LBRM cells also contained 0.02% 2-mercaptoethanol and the culture medium of the CTLL cells was supplemented with 10 mM Hepes (pH 7.3) and T-cell growth factor standardized to yield 50% of the maximal [3H]thymidine incorporation after 24h. The LBRM bioassay possesses an extreme sensitivity (0.01 unit of IL-1) and high specificity for IL-1 (17) . Nevertheless, we have also demonstrated, by use of polyclonal neutralizing antisera to IL-la and IL-1f3, respectively, that we indeed measured bioactivity of IL-la or IL-113 when employing this assay.
Preparation of RNA. Isolation of RNA from PC12 cells was performed using RNAzol B according to the supplier's instructions (Cinna/Biotecx). The following amplification protocol was used: 30 cycles of denaturing at 92°C (60 sec), primer annealing at 50'C (60 sec), and primer extension at 72°C (60 sec). The IL-la (sense) 5' primer used was 5'-GATGTGGTTGTCACAGTTAG-3', and the IL-la (antisense) 3' primer was 5'-TGCAGTCATGAT-CACCAATC-3', defining a 175-base target sequence in the 3'-untranslated region of rat IL-la cDNA (19) . In addition, amplifications were performed using primers specific for mouse ,B-actin. The 5' primer used was 5'-GTGGGCCGC-TCTAGGCACCA-3', and the 3' primer was 5'-TGGCCT-TAGGGTGCAGGGGG-3', defining a 242-base target on mouse f-actin cDNA (20) . All amplified cDNA were stained with ethidium bromide during agarose gel electrophoresis and photographed using Polaroid film, type 665 (Polaroid).
RESULTS
Constitutive expression of IL-la-LI in rat PC12 cells was demonstrated by immunohistochemistry using a rabbit polyclonal antiserum raised against rmIL-la (Fig. 1 ). An intense immunofluorescence was observed in the cytoplasm of all of the PC12 cells ( Fig. 1 A and B) , leaving the cell nuclei unstained (Fig. 1C) . To see the increase in IL-la-LI upon NGF treatment the antiserum was diluted further (1:8000 instead of 1:600) and the incubation was shortened to 24 h ( Fig. 1 C and D) . The NGF treatment of the cells caused neurite outgrowth (Fig. 1 A and C) and an increase in the IL-la immunofluorescence intensity (cf., Fig. 1 C and D) . A lower level of IL-la-LI, as compared to the soma, was observed in the neurites, although smaller dot-like or irregular regions were intensely fluorescent ( Fig. 1 A and C) . The IL-la-LI was abolished in both control (untreated; Fig. lE) and NGF-treated (data not shown) cells when the antiserum Increases in cellular IL-la-LI upon NGF treatment of PC12 cells were quantified using an IL-la-specific ELISA.
Treatment of PC12 cells with NGF (0.1-5.0 jig/ml of culture medium) for 3 days caused a dose-dependent increase in the cellular IL-la-LI as measured by ELISA. The dose-response curve was bell shaped with the maximum dose at 0.75 pkg/ml (Fig. 2) . The maximum increase was 500% above the concentration found in untreated control cells.
Incubation of NGF (0.75 ;Lg/ml of culture medium) with a neutralizing mouse monoclonal antibody against 2.5S NGF prior to the addition to the PC12 cells fully blocked the 7S NGF-induced increase in the IL-la-LI measured in the ELISA.
The bioactivity of the IL-la in PC12 cells was examined in a highly specific bioassay for IL-1, the LBRM33-lA5 cell conversion assay (17) . The effects of NGF on the IL-1 bioactivity, as examined in the bioassay, were time dependent when studied at a dose of 0.75 ,ug/ml (Fig. 3) . The maximal effect, 600%o of control, was attained after 3 days of treatment.
Proc. Nad. Acad Sci. USA 88 (1991) .Lg/ml of culture medium) for 1 h prior to addition to the PC12 cells.
The 100%o point corresponds to 1 unit of IL-la per 1 x 106 cells.
The increase in IL-1 bioactivity caused by NGF in the concentration range 0. 1-10.0 ,ug/ml (Fig. 4) showed the same bell-shaped dependence on NGF concentrations as IL-la-LI measured by ELISA. The bioactivity of the IL-1-like molecule in supernatants of PC12 cells could be partly inhibited by neutralizing antiserum to rmIL-la but not by neutralizing antiserum to rhIL-1/3 (data not shown).
Low constitutive expression of IL-la mRNA or no expression was identified in control (untreated) PC12 cells by PCR amplification. In the experiment shown in Fig. SA , there is no constitutive expression in the control (lane 4) whereas the NGF-treated 7S NGF (at 0.75 ,ug/ml for 3 days) PC12 cells show expression of IL-la mRNA (lane 5), measured as a PCR product. Neutralization of 7S NGF with monoclonal antibodies completely abolished the effect of NGF on IL-la mRNA expression (lane 6). Whereas expression of mRNA, from the same respective samples, coding for ,B-actin were not affected (lanes 1-3) . Fig. 5B shows an experiment where constitutive expression of IL-la in PC12 cells was seen (lane 3, upper gel) and the expression was induced after NGF treatment (0.75 ,ug/ml; lane 2, upper gel), whereas ,B-actin mRNA, amplified from the same respective samples, were not affected (lanes 2 and 3, lower gels).
DISCUSSION
The results presented demonstrate the constitutive expression of IL-la in the PC12 rat pheochromocytoma cells, which are widely used as a model system of sympathetic neurons in the study of NGF effects and of neurotransmitter synthesis and release (11, 21) . Immunohistochemistry showed that all PC12 cells express IL-la-LI and, after NGF treatment, there was an increase in IL-la immunofluorescence. The basal cellular content of IL-la varied significantly (by a factor of 2.5 between lowest and highest) during the 14 months of this study. The NGF treatment resulted in an induction of ILla-LI, IL-l bioactivity, and IL-la mRNA as measured by PCR, independent of the basal level found. The maximum effect, which was reproducible, corresponds to a 500-600% increase of the gene product, above levels found in non-NGF-treated PC12 cells.
The constitutive and inducible presence of IL-1 in a cell line of neural crest origin is of importance since until recently the assumption was that IL-1 is synthesized by macrophages, astroglia, or synovial cells stimulated by bacterial lipopolysaccharide (1, 22) . Even findings of IL-i-LI in the brain were until recently attributed, in most cases, to the microglia and astroglia rather than to neuronal origin (23 previous studies of the peripheral nervous system of the rat have demonstrated the occurrence of IL-i-LI in peripheral nerves (24) and in adrenal chromaffin cells of the medulla (9) . These findings are now extended to a well-defined cell line.
The effects of NGF in stimulating IL-1 biosynthesis and neurite outgrowth could be blocked by a specific neutralizing monoclonal antibody to 2.5S NGF, which recognizes both 2.5S and 7S forms. It should, however, be noted that the NGF doses required here are 5-to 10-fold higher than those used to differentiate PC12 cells (11) or induce protein phosphorylation (25, 26) . This discrepancy may stem from our use of the naturally occurring 7S form of NGF rather than the commonly used 2.5S form. However, the specificity ofthe 7S NGF effect is shown by the complete blockade achieved with the neutralizing monoclonal antibody (raised against 2.5S NGF). Furthermore, a time and dose dependency ofthe NGF treatment was observed. The IL-1 found in supernatants of rat PC12 cells is active in a specific bioassay for IL-1 and its activity can be blocked by a polyclonal rabbit antiserum to rmIL-la to an extent of 60%. The failure of an antiserum to rhIL-1l3 to block the remaining IL-1-like bioactivity may be related to species differences in the antigens.
The induction of IL-1 expression in nonneuronal cell types, such as macrophages and synovial cells, has earlier been shown to take place in response to lipopolysaccharide (1) but not in response to any known neuronally active substance. Thus the finding that NGF can alter the expression of IL-1 in a neural crest cell considerably enlarges the scope of cell types, substances, and influences that may call IL-1 into play in the nervous system.
Recent results indicate that IL-1f8-LI can be found in the olfactory tubercle, hippocampus, and hypothalamus of the rat (6) and that NGF mRNA and IL-1,3 mRNA may be colocalized in hippocampal pyramidal cells (8) , suggesting a possible interplay between IL-1 and NGF.
The main results of the present study are that the expression of immunologically crossreactive and bioactive IL-la, which is constitutively expressed, is also subject to induction by NGF. The significance ofthe ability ofNGF to induce IL-1 expression lies in the fact that IL-1 itself also acts as a growth factor that promotes glial proliferation (15, 16) . Even more important is the fact that IL-1 itself induces the expression of NGF in nonneuronal cells at peripheral nerve injury (14) . These results thus suggest some cross-regulation between these two growth signals that now can be studied in a convenient cell culture model.
